Can we advise ovulation induction in patients with SLE?

Area of Science:

• Rheumatology and Reproductive Endocrinology
• Immunology and Obstetrics

Background:

• Systemic lupus erythematosus (SLE) prognosis has significantly improved, enhancing patient survival and quality of life.
• Pregnancy, once contraindicated, is now feasible for many SLE patients with appropriate management.
• Improved SLE outcomes raise questions about fertility treatments for patients experiencing infertility.

Purpose of the Study:

• To review the theoretical and practical considerations of ovulation induction (OI) in patients with SLE.
• To address the safety and efficacy of OI and in vitro fertilization (IVF) in SLE management.
• To explore the implications of estrogen's role in SLE pathogenesis on fertility treatments.

Main Methods:

• Review of existing literature on ovulation induction (OI) in systemic lupus erythematosus (SLE).
• Analysis of theoretical risks and benefits associated with OI and IVF in SLE patients.
• Discussion of clinical management strategies for fertility treatments in SLE.

Main Results:

• Data on OI and IVF in SLE patients remain scarce.
• Estrogen's role in SLE pathogenesis necessitates careful consideration for fertility treatments.
• Appropriate management allows for successful pregnancies in a majority of SLE patients.

Conclusions:

• Ovulation induction (OI) and in vitro fertilization (IVF) are increasingly relevant considerations for SLE patients.
• Further research is needed to establish optimal protocols for fertility treatments in SLE.
• Careful patient selection and management are crucial for successful outcomes in SLE fertility therapies.